The companies involved plan to focus first on the 3 most important diseases: 1. Hypertension (160 million people), 2. Obesity (over 200 million), and 3. Diabetes (20 million confirmed cases). The service will look for personalized management of consultation, health monitoring, health intervention, dietary guidance and sleep and psychological management.

China Bio news release, January 25, 2016